Comparison of trend analysis of varicella zoster disease burden between China and the world 1990–2021 and disease burden forecast 2030

Objectives: This study aims to analyze temporal trends in the age- and sex-specific burdens of varicella zoster virus (VZV), including incidence, prevalence, mortality, and disability-adjusted life years (DALYs) in China from 1990 to 2021, and to predict the burden of varicella zoster in China for 2030 by comparing the trends with the global burden of the disease. Methods: Data from the Global Burden of Disease database (1990-2021) were used to analyze the characteristics of varicella zoster virus (VZV) burden in China and globally, including trends in incidence, prevalence, mortality, and disability-adjusted life years (DALYs). The average annual percentage change (AAPC) and its corresponding 95% confidence interval (95% CI) were calculated using Joinpoint to assess the VZV burden trends. A comprehensive comparative analysis of the differences in VZV burden between China and the global population was conducted across multiple dimensions, including age, gender, and time period. Additionally, an autoregressive integrated moving average (ARIMA) model was used to predict the VZV trend from 2021 to 2030. Results: Between 1990 and 2021, the age-standardized incidence rate (ASIR) of varicella zoster in China decreased from 1,274.93/100,000 to 1,270.58/100,000, while the global ASIR increased from 1,244.05/100,000 to 1,248.59/100,000. In China, the age-standardized prevalence rate (ASPR) decreased slightly from 72.27/100,000 to 72.03/100,000, whereas the global ASPR rose from 66.67/100,000 to 67.16/100,000. The age-standardized disability-adjusted life year rate (ASDR) in China decreased significantly, from 17.68/100,000 to 4.66/100,000, while the global ASDR decreased from 19.28/100,000 to 12.31/100,000. Similarly, China's age-standardized mortality rate (ASMR) declined significantly, from 0.40/100,000 to 0.05/100,000, while the global ASMR decreased from 0.35/100,000 to 0.19/100,000. Over the same period, the average annual percentage change (AAPC) of ASIR, ASPR, ASMR, and ASDR in China was -0.0056, -0.0131%, -6.84%, and -4.24%, respectively, while the global AAPC for these metrics was 0.0119, 0.0183, -1.97%, and -1.42%, respectively. Additionally, age and gender had a significant impact on the burden of varicella zoster. The trends in ASIR and ASPR were notably influenced by age, while ASMR and ASDR exhibited a significant increasing trend with age. Projections indicate that the ASDR of varicella zoster in China will continue to decrease by 2030, while the ASIR, ASPR, and ASMR are expected to remain stable. Conclusion: Between 1990 and 2021, the incidence, prevalence, mortality, and DALYs of VZV in China demonstrated a declining trend, reflecting a relative reduction in the VZV burden. Women are more susceptible to VZV infection and face a higher risk of mortality than men. In contrast, the global disease burden remains higher than that in China. Projections suggest a slight decrease in the VZV burden in China by 2030. However, due to the country's large and aging population, VZV will continue to pose a significant public health challenge

Autoregressive integrated moving average · Burden of disease · China · Confidence interval · Disease · Disease burden · Environmental health · Geography · Population · Statistics · Time series · Demography · Herpesvirus Infections and Treatments · Medicine · Poxvirus research and outbreaks · Sperm and Testicular Function · Epidemiology · Gerontology · Internal Medicine · Pediatrics

• Spatial–temporal patterns, seasonality, and age-specific trends of varicella in Hangzhou, China, 2019–2024

  Open Access•Lintao Gu, Yan Liu et al.•Frontiers in Public Health•2026

  Incluir item

• Early appraisal of China's huge and complex health-care reforms

  Open Access•Winnie Yip, Winnie Chi-Man Yip et al.•The Lancet•2012

  Incluir item

• Years of health-care reform in China

  Open Access•Winnie Yip, Hongqiao Fu et al.•The Lancet•2019

  Incluir item

• Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019

  Open Access•Theo Vos, Stephen S Lim et al.•The Lancet•2020

  Incluir item

• Long-term trends in the burden of inflammatory bowel disease in China over three decades

  Open Access•Yang Zhang, Ambroise Mazal et al.•Frontiers in Public Health•2022

  Incluir item

• Three in four children age 12–23 months missed opportunities for vaccination in Sub-Saharan African countries

  Open Access•Melak Jejaw, Tesfahun Zemene Tafere et al.•BMC Public Health•2025

  Incluir item

• Trends in cervical cancer mortality in China from 1989 to 2018

  Open Access•Menghan Guo, Juan Xu et al.•BMC Public Health•2021

  Incluir item

• Effectiveness of a 2-dose varicella vaccination program in Changzhou, China, during the transitional period (2017–2022)

  Open Access•Shuting Xiong, Suting Xiong et al.•BMC Public Health•2025

  Incluir item